Two silkmoth nuclear receptor isoforms, BmHNF-4a and BmHNF-4b, that are related to the mammalian orphan receptor HNF-4, were characterized. Their characterization revealed that they differ from each other only in their 5′ UTR and N-terminus of the predicted polypeptides. In ovarian tissue, the two receptors are expressed as a delayed response to 20-hydroxy-ecdysone and their expression increases during vitellogenesis. BmHNF-4 mRNA is localized in the cytoplasm of follicular cells and a binding activity that recognizes a mammalian HNF-4 response element is present in follicular cell nuclear extracts. BmHNF-4 mRNA is also present in the oocyte, the unfertilized egg and the early embryo, thus displaying a behavior reminiscent of maternal mRNA. Both mRNA isoforms are found in the embryo following fertilization and their abundance is modulated during ensuing embryogenesis. In contrast to the rather limited distribution of HNF-4 in mammalian tissues, BmHNF-4 is expressed in most larval and pharate adult tissues of the silkmoth.
Introduction
In the domesticated silkmoth, Bombyx mori, ovarian development is induced by the moulting hormone, 20-hydroxy-ecdysone (20E), during the transition from the 5th instar larval to the pupal stage (Yamauchi and Yoshitake, 1984) . Ovarian development is characterized by the assembly, growth and differentiation of follicles, each of which consists of three cell types, the oocyte and nurse cells, both derived from the germ line, and the mesodermal follicular cells that form an epithelium around oocyte and nurse cells. The development of ovarian follicles occurs asynchronously and is completed prior to adult eclosion, which occurs 10 days after pupation. At the time of eclosion, each of the eight ovarioles contains 80-100 mature eggs (ovulated follicles). At earlier stages of pharate adult development, each ovariole contains approximately 120 developing follicles arranged in a linear array, with each follicle along the length of the developing ovariole representing a specific (and unique) stage of follicle development; developing follicles differ from their adjacent neighbors by approximately 2 h in the developmental program (Swevers and Iatrou, 1992) . The most advanced follicles enter vitellogenesis as early as the spinning stage (Yano et al., 1994) , while choriogenesis is initiated by the first (terminal) follicles 5 days after larval-pupal ecdysis (Swevers and Iatrou, 1992) .
Because silkmoth ovarioles consist of long arrays of more than 100 follicles that differ from each other only by a short developmental period, they represent a unique system to study long-term developmental programs. Earlier research has focused on the characterization and developmental expression of the chorion genes, which become expressed in the follicular epithelia during their terminal differentiation (Kafatos et al., 1995) . Analysis of the regulatory regions of the chorion genes has lead to the isolation of transcription factors that bind specifically to DNA recognition sites, thus identifying upstream elements in the developmental program (Skeiky and Iatrou, 1991; Drevet et al., 1994) . Moreover, in vitro culture studies have indicated that chorion gene expression in the follicular cells becomes established as an autonomous developmental program during mid-vitellogenesis (Swevers and Iatrou, 1992) . A major element in the signal transduction cascade involves the regulation of the distribution between cytoplasm and nucleus of GATA-type transcription factors by a phosphorylation/ dephosphorylation signal transduction mechanism .
The recent identification of key elements in the differentiation program with respect to the transition from vitellogenesis to choriogenesis contrasts with our limited knowledge of the regulation of the first steps of follicular development, which are initiated by the hormone 20E. In this paper, we report on the identification of two silkmoth transcription factors, homologs of the mammalian orphan nuclear receptor HNF-4, as components of follicular cell differentiation. BmHNF-4 becomes strongly expressed when the ovary starts to develop at the beginning of metamorphosis, in response to rising titers of 20E in the hemolymph. After induction, BmHNF-4 expression is maintained in follicular cells (and to a lower extent, also in nurse cells), implying a role for BmHNF-4 in the expression of follicular cell-specific genes, irrespective of the differentiation status of the follicles.
Our results also challenge the notion that the HNF-4 class of orphan receptors encompasses members that are only expressed in liver, kidney and intestine or in the functional analogs of insects (fat body, Malpighian tubules and gut; Sladek et al., 1990; Zhong et al., 1993) . BmHNF-4 is expressed in most larval and pharate adult tissues of the silkmoth, but shows tissue-specific accumulation of different isoforms.
Results

Characterization of cDNA clones encoding the silkmoth homolog of HNF-4
When a cDNA library generated from vitellogenic follicular cell mRNA was screened with a probe specific for the DNA binding domain of the silkmoth ecdysone receptor (BmEcR), weakly hybridizing clones were obtained besides the strongly hybridizing ones that encoded BmEcR. In total, six clones were characterized and the sequence of BmHNF-4 was reconstructed after complete sequencing of overlapping clones.
The sequences of the clones could be grouped into two classes with respect to their 5′ ends. The longest sequence obtained for the first class, BmHNF-4a (three isolates), is shown in Fig. 1A . The longest cDNA has a unique 5′ end of 319 bp, consisting of 213 bp of 5′ UTR and 32 codons of the N-terminus of the polypeptide. Fig. 1B shows the longest unique 5′ end, derived from the three other cDNA isolates belonging to the second class, BmHNF-4b. The longest BmHNF-4b cDNA has a unique 5′ end of 150 bp, consisting of 132 bp of 5′ UTR and six codons of the N-terminus of the polypeptide. The methionine codons indicated in Fig. 1A ,B correspond to the translation start sites of BmHNF-4a and 4b because they are preceded by stop codons in all reading frames of the 5′ UTR. No differences were observed between BmHNF-4a and BmHNF-4b cDNAs in the rest of their coding regions and 3′ UTRs. Due to the differences in their N-termini, the putative polypeptides encoded by BmHNF-4a and BmHNF-4b mRNA contain 436 and 410 amino acids corresponding to molecular masses of 48.9 and 46.0 kDa, respectively.
The open reading frames (ORFs) of the characterized clones exhibit the five domain structure, A/B-F, characteristic of the members of the nuclear hormone receptor superfamily (Fig. 1C) . The amino acid sequences of BmHNF-4 and the human, mouse and Drosophila homologues were aligned and the percentage identity at the amino acid level was calculated for the different domains (Table 1) . The DNA binding domain shows the highest identity among different species (88-97%; Table 1 ). The P-box, thought to be an important determinant of the binding specificity of nuclear hormone receptors (Jiang et al., 1995) , is also present in BmHNF-4 and has the same sequence, CDGCKG, as that found in all HNF-4 polypeptides described to date (Fig. 1A) . The ligand-binding domain is also very conserved among Bombyx, Drosophila, mouse and human (66-75% identity), and significant similarities are also found in the hinge region (48-57%). In contrast, the sequences of the N-terminal (A/B domain) and C-terminal (F domain) regions of the polypeptides of the different species show no pronounced sequence similarities ( Table 1 ). The sequence of the F domain of BmHNF-4 is rich in proline residues (25%) and contains several triplet LVP and QLP amino acid repeats (Fig. 1A) whose functional significance is unknown. Fig. 1 . BmHNF-4 cDNA sequences. (A) The longest nucleotide sequence determined for BmHNF-4a is shown together with the amino acid sequence encoded by it. The boundaries of the five domains, A/B to F, characteristic for the nuclear hormone receptor superfamily, are indicated by vertical bars. The cysteine residues of the zinc finger motifs in the DNA binding domain are shown in bold italic and the residues involved in DNA half-site recognition (P-box; Jiang et al., 1995) are bold and underlined. A putative poly-adenylation signal in the 3′ UTR is underlined. A putative splice site involved in the generation of BmHNF-4 isoforms is indicated by the arrow; the sequence upstream of this site is unique to BmHNF-4a. (B) The longest nucleotide sequence determined for the 5′ end of BmHNF-4b is displayed together with the amino acid sequence of the N-terminus of the polypeptide encoded by it. The vertical arrow indicates the site at which sequences of BmHNF-4b diverge from BmHNF-4a. (C) Drawing of the polypeptide structures of the two BmHNF-4 isoforms isolated from the ovarian cDNA library. Shown is the five domain structure characteristic for nuclear hormone receptors (Green and Chambon, 1988) . The unique Ntermini of the A/B-domain in BmHNF-4a and BmHNF-4b are indicated by the black regions.
BmHNF-4 mRNA is encoded by a single copy gene
When a 0.4 kb NotI/ClaI-fragment containing the ligand binding and F domains of BmHNF-4 was used as a probe in Southern hybridizations of restricted Bombyx DNA (Fig.  2) , one strongly hybridizing band was observed in the genomic DNA digest with XhoI while two strong bands were detected in the digests with EcoRI. Because the two signals in the EcoRI digests reflect the presence of an internal EcoRI site in the probe used, these hybridizations suggest that a single BmHNF-4 gene exists in the silkmoth genome.
The presence of one or two, weakly hybridizing bands in each lane of the digests was also noted (Fig. 2) . The weakness of these hybridization signals suggests that although BmHNF-4 is a single copy gene, there is at least one closely related homologue in the silkmoth genome.
BmHNF-4 expression is induced in the ovary at the beginning of metamorphosis
Ovarian follicle development in silkmoths commences during the larval-pupal transition (Yamauchi and Yoshitake, 1984) , which is controlled by two peaks in the titer of the hormone 20E in the hemolymph. The first peak occurs at the beginning of the spinning stage and induces pupal development while the second pulse occurs during the first and second day of pupation and triggers adult development (Calvez et al., 1976; Tsuchida et al., 1987) . As shown in Fig. 3 , the prevalence of BmHNF-4 mRNA in ovarian extracts increases concomitant with the rises of ecdysteroid titer in hemolymph, i.e., during the last day of spinning and 1 day after pupal ecdysis ( Fig. 3A) .
Given the apparent 20E-mediated induction of BmHNF-4 mRNA synthesis, the effect of 20E on ovarian BmHNF-4 expression was also directly tested. Day 3 spinning larvae were developmentally arrested by a ligation between thorax and abdomen. Adult development, including ovarian maturation, in the isolated abdomens was induced 3 days later by a single injection of 20E (Ohnishi, 1987) . As shown in Fig. 3B , BmHNF-4 mRNA (total and a-isoform) levels start to increase in ovarian tissue 6 h after hormone injection and reach their maximum level after 24 h. Transcript accumulation between 6 and 24 h is characteristic of 20E late response genes and suggests a dependence on additional factors encoded by early hormone response genes. In contrast to the a-isoform, BmHNF-4b mRNA is not up-regulated by the hormone in isolated abdomens. Considering that in ovaries of intact pupae an increase in BmHNF-4b mRNA accumulation was seen (Fig. 3A) , the lack of BmHNF-4b mRNA induction upon 20E administration suggests a dependence on additional factors. This differential response to 20E also suggests that BmHNF-4a and Indicated are the length of the different domains (number of amino acids) and the identity versus BmHNF-4 expressed as % of the BmHNF-4 sequence.
BmHNF-4b mRNA transcription is controlled by two different promoters.
Expression of BmHNF-4 mRNA in developing ovarian follicles
The expression of BmHNF-4 in the cells surrounding the oocyte of developing follicles (nurse and follicular epithelium cells for vitellogenic follicles; follicular epithelium cells only for choriogenic follicles) at different developmental stages was examined by Northern and in situ hybridizations. For the Northern hybridizations, three BmHNF-4-specific probes were used: two of them were specific for the two mRNA isoforms, while the third one encompassed the ligand binding domain that is present in both isoforms. In situ hybridizations, on the other hand, were carried out using RNA probes that encompassed sequences shared by the two mRNA isoforms.
Although the hybridization signal intensities obtained from the Northern hybridizations varied depending on the Fig. 4 . Northern blot analysis of expression of BmHNF-4 mRNA in follicular/nurse cells during follicle maturation. Numbers refer to follicle stages with respect to the start of choriogenesis [+1; for staging system see Swevers and Iatrou (1992) ]. T refers to stages earlier than −30. The first three panels show hybridization signals specific to BmHNF-4a, BmHNF-4b and all BmHNF-4 isoforms. All three probes detect a mRNA of 4.5 kb. The lower panel shows control hybridizations to actin (1.3 kb; integrity of all RNA samples) and early chorion genes (0.5 and 0.4 kb; start of choriogenesis). Exposure times were 4 days for the a-isoform-specific probe, 8 days for the b-isoform-specific probe, 2 days for the common probe and 4 h for the actin and early chorion gene probes. Please note also the transient increase in the level of cytoplasmic actin mRNA at the onset of choriogenesis; this increase is genuine (Swevers et al., 1995) and not due to overloading of the lanes containing choriogenic follicular cell RNA (based on ethidium bromide staining intensity prior to transfer of the RNA to the hybridization membranes; data not shown). Fig. 4 . In addition, hybridizations were carried out with a probe specific for BmHR3 for the samples obtained from developing ovaries in isolated abdomens. Sizes of mRNA are 4.5 kb (BmHNF-4), 1.3 kb (actin) and 4.8 kb (BmHR3). Panel A: L5, 5th instar larvae; P0, 1-6 h after pupal ecdysis; P1, 24 h after pupal ecdysis; SL, spinning larvae. Panel B: numbers refer to time intervals in hours following injection of 20E. In both panels, exposure times were 4 days for the 'A-form' and 'B-form' probes, 12 h for the 'common' probe and 4 h for the actin probe. In panel B, the exposure time for the BmHR3 probe was 12 h. probe used, a similar pattern of expression was obtained with all probes (Fig. 4) . A single mRNA species, approximately 4.5 kb in length, was detected that showed modulations in expression during follicular cell development. Messenger RNA levels are high in previtellogenic follicles (lane T of Fig. 4 ), decline during early vitellogenesis (until stages −26/−23; see Swevers and Iatrou (1992) for staging of follicles) and increase again during middle vitellogenesis (stages −21/−22 until −9/−10). After a pronounced decline during late vitellogenesis (stages −7/−8 until −1/−2), an increase in the level of BmHNF-4 mRNA was again observed during early choriogenesis (stages +1/+2 to +5/ +6).
In order to determine the cell type in which BmHNF-4 is expressed, whole mount in situ hybridizations were carried out. Specific signals were detected only with the antisense probe in follicular cells of middle vitellogenic (approximate stages −30 to −11), late vitellogenic (−10 to −1) and choriogenic follicles (Fig. 5, upper panel) , and the staining was seen exclusively in the cytoplasm of the cells. Only background staining was detectable in the cells with the BmHNF-4 sense RNA riboprobe (Fig. 5, middle panel) . Control hybridizations using the chorion antisense RNA probe resulted in the detection of strong signals solely in the cytoplasm of follicular cells of early choriogenic follicles (Fig. 5, lower panel) . Again, only background staining was observed with the chorion sense RNA riboprobe (data not shown).
An HNF-4 binding activity is present in follicular cell nuclear extracts
Studies with mammalian and Drosophila HNF-4 have shown that these factors bind to their DNA recognition sites as homodimers (Zhong et al., 1993) . The binding sites consist of two hexamer elements organized as direct repeats with 1 bp spacing (Jiang et al., 1995; Mangelsdorf et al., 1995) . To determine whether BmHNF-4 binds to similar DNA elements, a truncated form of BmHNF-4b lacking part of the F domain was synthesized in vitro and tested for binding to an HNF-4 binding site derived from the human apolipoprotein CIII promoter (APF1) (Sladek et al., 1990; Fig. 6) .
As shown in Fig. 6A , strong and specific binding of the in vitro synthesized BmHNF-4 to the APF1 site was observed in gel retardation assays, while no complex formation was detectable with the unprogrammed control lysate. By contrast, BmHNF-4 was unable to bind to two other nuclear receptor binding sites, a 20E receptor response element of the Drosophila hsp27 gene (Koelle et al., 1991) and a USPbinding site of the Drosophila S15 chorion gene (KhouryChristianson et al., 1992 ) (data not shown).
Nuclear extracts prepared from the non-oocyte fractions of follicles dissected from a 5 day pupa were subsequently tested for binding to the APF1 probe. As shown in Fig. 6B , two specific complexes were formed by follicular and nurse cell nuclear proteins; one of them migrated slower while the second one migrated faster than the complex formed by the in vitro made BmHNF-4. The differences in complex mobility may be due to post-translational modifications of BmHNF-4, formation of higher order complexes involving additional factors, or even binding of other BmHNF-4-like factors to the probe used in these experiments. In more detailed experiments, no quantitative or qualitative differences were observed between extracts derived from vitellogenic follicles, which contain follicular or nurse cells, and those prepared from choriogenic follicles, which contain follicular cells but are devoid of nurse cells (data not shown). Therefore, BmHNF-4 or BmHNF-4-like factors may have a role in the differentiation of follicular cells.
BmHNF-4 mRNA expression during embryogenesis, larval and pharate adult life
As shown in Fig. 7 (left panel) , BmHNF-4 mRNA is present in ovulated follicles that are devoid of oocyteassociated cells. This finding suggests that BmHNF-4 may also function as a maternal mRNA for early embryogenesis. The relative prevalence of BmHNF-4 mRNA, as detected by all three probes, was found to increase within 6 h postfertilization (preblastoderm stage embryos), presumably as a result of zygotic activation, but to decline subsequently (days 1 and 2 of embryonic development). However, although the levels of BmHNF-4a and BmHNF-4b mRNA on the second day of embryonic development were lower than those of day 1, the total levels of BmHNF-4 remained constant, suggesting that another isoform of BmHNF-4 may be preferentially expressed upon activation of the zygotic genome. In fact, partial sequencing of additional HNF-4 cDNA clone isolates revealed the existence of at least one additional HNF-4 isoform that differs in its F domain and 3′ UTR from the two isoforms reported here (data not shown).
To examine whether BmHNF-4 mRNA is expressed after the conclusion of embryonic development, RNA was extracted from different larval and pharate adult tissues and subjected to a similar hybridization analysis. The hybridizations, shown in Fig. 7 (middle panel), revealed that BmHNF-4 is expressed in all larval tissues except for the silk gland. The hybridizations with the isoform-specific probes revealed that BmHNF-4a is mainly present in the fat body, gut and Malpighian tubules, while BmHNF-4b, which is detectable in all tissues except for the silkgland, is predominantly expressed in the testis. The hybridization patterns obtained with the common probe suggest again that additional BmHNF-4 mRNA isoforms may be expressed in tissues such as the Malpighian tubules and the muscle. In pharate adults, BmHNF-4 mRNA was also found to be expressed to various extents in all tissues examined (Fig.  7, right panel) . The BmHNF-4a isoform was found to be expressed predominantly in the ovary (both in the follicular/ nurse cell complex and in the oocyte fraction) and the fat body, while BmHNF-4b was again found to be expressed at high levels in the testis. Thus, in contrast to the mammalian HNF-4 which has a limited tissue distribution, BmHNF-4 expression appears to be very widespread during postembryonic life.
Discussion
In this report, we have described the identification, developmental analysis and an initial functional characterization of two silkmoth orphan receptors that share pronounced sequence similarities with the mammalian nuclear hormone receptor HNF-4. Two isoforms of Bombyx HNF-4, a and b, have been characterized, which differ from each other only in their N-terminal sequences. A third isoform that differs from the other two in its C-terminal domain and 3′ UTR has also been identified but not yet fully characterized.
Because the N-terminal (A/B) domains of nuclear receptors encompass important transactivation functions (Gronemeyer, 1993; Drewes et al., 1996) , the two characterized isoforms of BmHNF-4 must regulate the expression of different sets of genes. The observed differential expression of the two mRNA isoforms, the most striking examples being the abundant expression of BmHNF-4b in the larval and pharate adult testis and the preferential accumulation of BmHNF-4a in the pharate adult ovary and fat body, supports this notion. In the ovary, the two BmHNF-4 isoforms also show a differential response to 20E, indicating that they are regulated by different promoters. Regulation by different promoters may reflect a differential requirement with respect to tissue or developmental stage. Furthermore, because BmHNF-4 can form dimers due to the presence of a strong dimerization interface in the ligand-binding domain (Jiang et al., 1995) , it is also possible that heterodimers may form by association of partners containing different N-termini. Therefore, the presence of two BmHNF-4 isoforms in the ovary and other tissues may result in the generation of three types of BmHNF-4 dimers, each of which could have unique transactivation properties.
BmHNF-4 mRNA becomes expressed in the ovary at the beginning of metamorphosis as a delayed response to 20E (Fig. 3) . Its accumulation at the time when ovarian growth is induced points to its importance for ovarian follicle development. In ovarian follicles, BmHNF-4 is expressed in both somatic and germ line cells. In situ hybridization shows that considerable amounts of BmHNF-4 mRNA accumulate in the cytoplasm of follicular cells of late vitellogenic and choriogenic follicles (Fig. 5, upper panel) , suggesting that the transcription factors encoded by these mRNAs may have a role in the developmental program that governs follicular cell differentiation. In addition, follicular cell nuclear extracts prepared from vitellogenic and choriogenic follicles contain a factor(s) which binds to an HNF-4 response element yielding two specific complexes. A conclusive demonstration that these binding proteins are BmHNF-4 will require generation of specific antibodies for the cloned factors and their employment to disrupt or supershift the specific complexes observed in the gel retardation assay.
Our RNA hybridizations have also shown that BmHNF-4 mRNA accumulates in the oocyte and that it persists in mature eggs after oviposition (Fig. 7) . Thus, BmHNF-4 mRNA must also be produced by the nurse cells and subsequently transported in the oocyte during oogenesis.
Judging from the Northern hybridizations, BmHNF-4 mRNA is present in follicles of all developmental stages, but its expression is modulated during oogenesis (Fig. 4) . However, abundant accumulation of BmHNF-4 mRNA was evident by in situ hybridization only during late vitellogenesis and choriogenesis and only in the cells of the follicular epithelium, while no signals were evident either in the nurse cells or the oocytes (Fig. 5) . Although at first glance the two experimental approaches appear to yield contradictory results, it should be remembered that the Northern analysis compares expression levels on a per mass basis of total RNA loaded on the gels and that developing follicles differ from one another in their RNA content (each choriogenic and late vitellogenic follicle contains approximately 5-10 times more RNA than each follicle of earlier vitellogenic stages). Thus, while in the Northern hybridizations early vitellogenic follicles were seen to contain 2-3 times more BmHNF-4 mRNA than late vitellogenic and choriogenic follicles, the actual BmHNF-4 mRNA content of each early or middle vitellogenic follicle is actually 2-3 times lower than the content of each late vitellogenic or choriogenic follicle and, possibly, below the limit of detection for in situ hybridization. The lack of detection of BmHNF-4 mRNA in the oocyte by in situ hybridization is probably due to the dilution of the mRNA over the large volume of the oocyte.
The dual pattern of expression of the BmHNF-4 gene during oogenesis (accumulation of maternal mRNA in the oocyte fraction, and mRNA and DNA binding protein present in the nuclei of follicular cells) bears a striking resemblance to the expression pattern of the GAGA factor during Drosophila oogenesis (Bhat et al., 1996) . In situ hybridization experiments have shown that GAGA mRNA is produced by the nurse cells during early and middle vitellogenesis, and accumulates as a maternal mRNA in the oocyte during late vitellogenesis. Because the GAGA protein is detected in the nuclei of germ line cells and somatic cells at many stages of oogenesis, it was suggested that the GAGA factor represents an important cofactor for the transcription of many follicular and nurse cell-specific genes, irrespective of their differentiation status. BmHNF-4 may play a similar role in the Bombyx ovary: its expression during many stages of follicular development suggests that it may function as an important transcriptional cofactor facilitating gene transcription in nurse and follicular cells throughout their developmental career.
The analysis of the expression of BmHNF-4 mRNA during embryogenesis suggests that the polypeptides encoded by the BmHNF-4 gene are required during both early and more advanced stages of embryogenesis. High levels of BmHNF-4 mRNA are found in the egg during the first hours after fertilization (blastoderm formation; Ueno et al., 1995) but its abundance declines during germ band formation (1 day after oviposition) and gastrulation/stomodeum-proctodeum formation (1-2 days after oviposition). This pattern of temporal expression is consistent with the prediction that BmHNF-4 plays a role in the terminal patterning and gut formation, as has been suggested for Drosophila HNF-4 (Zhong et al., 1993) .
Finally, the presence of BmHNF-4 mRNA in the majority of the larval and pharate adult tissues suggests that the corresponding polypeptides also function as tissue-specific transcription factors that may be coordinated by other nuclear factors having tissue-specific distributions.
Experimental procedures
Animals
The silkworm strain used in this study was a hybrid obtained from the Forest Pest Management Institute, Sault Ste-Marie, Canada. Rearing of larvae, pupae and moths was carried out as previously described (Swevers and Iatrou, 1992; Ikeda et al., 1993) .
Physiological experiments
Developmentally arrested pupae were obtained by ligating day 3 spinning larvae between the thorax and the abdomen using silk thread. After removal of the head and thorax, developmentally arrested abdomens were kept at 25°C for at least 3 days before any further experimental manipulation. Ten micrograms of 20-hydroxy-ecdysone (20E; Sigma), dissolved in 5 ml of 50% ethanol, was injected into isolated abdomens through the lateral intersegmental membrane between the 5th and 6th abdominal segments. Ovaries were dissected from injected abdomens at different times and RNA and nuclear extracts were prepared as described below.
cDNA library screening
A cDNA library made from poly(A) + RNA isolated from follicular cells of vitellogenic follicles (Swevers et al., 1995) was initially screened with a 120 bp fragment specific for the DNA binding domain of the 20E receptor of B. mori (BmEcR; Swevers et al., 1995) , and subsequently with a 0.4 kb NotI-ClaI fragment corresponding to the ligand-binding and F domains of BmHNF-4 isolated from the first screen. Hybridizing clones were plaque purified and inserts subcloned into the NotI or EcoRI sites of Bluescript SK + (pBS-SK + ).
DNA sequence analysis
Dideoxynucleotide sequencing (Chen and Seeburg, 1985) was carried out using double-stranded DNA and Sequenase (US Biochemical Corp.). Sequence comparisons were performed using the GCG (Genetics Computer, Inc.) sequence analysis software package.
Nucleic acid extraction
Genomic DNA was prepared from silkgland tissue as described . RNA was prepared from eggs and tissues as previously described (Skeiky and Iatrou, 1991) . For developing ovarian follicles, attention was paid to ensure that lysis occurred solely for the cells surrounding the oocyte and that the oocytes were not disrupted during lysis. Extracts of choriogenic follicles contain only RNA present in the follicular epithelium because of the absence of nurse cells at this stage. In extracts of vitellogenic follicles, however, a substantial proportion of the RNA is derived from nurse cells. To obtain RNA from oocytes, fresh lysis buffer was added to the oocytes after the removal of the follicular cell/nurse cell extract supernatant, and oocytes were subsequently processed for RNA extraction. Finally, because follicles of immature ovaries from larvae and early pupae are still enclosed in a protective capsule, RNA from immature ovaries was prepared by homogenizing the whole tissue.
Hybridization probes
For filter hybridizations, the following DNA fragments were labeled by random priming (Feinberg and Vogelstein, 1983 ) and used as probes: (a) a 293 bp NotI-XhoI fragment specific for the 5′ untranslated region (UTR) and N-terminus of the coding region of BmHNF-4a; (b) a 141 bp NotIPvuII fragment specific for the 5′ UTR and N-terminus of the coding region of BmHNF-4b; (c) a 417 bp ClaI-NotI fragment specific for the ligand-binding and F domains of BmHNF-4; (d) a 1.8 kb PstI fragment of the actin A3 gene (Mounier and Prudhomme, 1986) ; (e) two PstI fragments of two early chorion cDNAs, 6A2 and 6C11 (Eickbush et al., 1985; Lecanidou et al., 1986; Swevers et al., 1995) and (f) a 270 bp PCR fragment corresponding to the DNA binding domain of an early-late ecdysone response gene, BmHR3 (T. Eystathioy and K. Iatrou, unpublished data). For in situ hybridizations, digoxigenin-labeled RNA probes were synthesized by in vitro transcription reactions in the presence of digoxigenin-11-UTP (Boehringer-Mannheim) using linearized plasmid DNA as template with T7 or T3 polymerase according to the manufacturer's instructions. Early chorion sense and antisense RNA was synthesized using as template cDNA clone 6C11 (0.45 kb PstI fragment in pBS-SK + ; Lecanidou et al., 1986) and T7 or T3 RNA polymerase, following linearization with HindIII and BamHI, respectively. BmHNF-4 antisense and sense RNA was synthesized using two BmHNF-4b clones as substrate (1.2 kb NotI-fragment cloned in two orientations in pBS-SK + ; BamHI-linearized). This clone contains the 5′ UTR of BmHNF-4b and its coding region from the N-terminus to an internal NotI-site in the F domain. Before use, the sizes of the probes were reduced to an average of 150 nucleotides by alkaline hydrolysis (Brahic and Haase, 1978; Cox et al., 1984) .
Filter hybridizations
For Southern blot analysis, 5 mg of genomic DNA was digested with appropriate restriction enzymes and transferred to Hybond-N + nylon membrane (Amersham) using 10 × SSC . For Northern blot analysis, 5 mg aliquots of RNA were analyzed as described (Swevers et al., 1995) . All hybridizations and washes were carried out at 68°C, except for the probe specific for BmHNF-4b, which was used at 62°C.
Whole-mount in situ hybridizations
Ovarioles dissected from day 5 pharate adults were fixed for 1 h at room temperature with 3.7% formaldehyde in phosphate-buffered saline (PBS, 150 mM NaCl, 10 mM Na-phosphate buffer pH 7). After washing with PBS containing 0.3% Triton X-100 (PBST), the ovarioles were treated successively with collagenase (0.5 mg/ml in PBST for 15 min at room temperature) and proteinase K (1 mg/ml in 100 mM Tris-HCl pH 8, 50 mM EDTA). At the end of the proteinase K treatment, the ovarioles were washed in PBS and refixed for 20 min with 3.7% formaldehyde in PBS. Following washing with PBS, the ovarioles were acetylated with 25 mM acetic anhydride in 0.1 M triethanolamine, pH 8 for 10 min at room temperature, washed with PBS, and incubated for 1 h at room temperature in prehybridization buffer (50% formamide, 0.25 M NaCl, 10 mM Tris-HCl pH 7.5, 1 mM EDTA, 1 × Denhardt's, 1 mg/ml salmon sperm DNA, 1 mg/ml yeast tRNA, 0.1 mg/ml poly-adenylic acid, 20 mM EDTA). After removal of the prehybridization buffer, the ovarioles were transferred to 1.5 ml tubes containing 0.2 ml of hybridization buffer (prehybridization buffer supplemented with 1/5 volume of 50% dextran sulphate in 50% formamide, 0.6 M NaCl; final salt concentration is 0.32 M NaCl). The latter included 150-400 ng/ml digoxigeninlabeled RNA probe and was pre-incubated at 90°C for 3 min before use. Hybridization was carried out for 16 h at 50°C with continuous shaking. Following hybridization, the ovarioles were washed extensively at room temperature with wash buffer (0.3 M NaCl, 10 mM Tris-HCl pH 6.8, 10 mM Na-phosphate buffer, 5mM EDTA, 50% formamide) and the non-hybridized excess RNA was removed by incubation in NTE-buffer (0.5 M NaCl, 10 mM TrisHCl pH 8, 1 mM EDTA) containing 1 U/ml RNase T1 and 20 mg/ml RNase A. Post-hybridization washes were carried out with 2 × SSC (once for 30 min at 50°C) and 0.1 × SSC (three times; 15 min at 50°C, 15 min at 55°C and 30 min at room temperature). The tissue was transferred to PBST and RNA hybrids were detected by immunohistochemistry using anti-digoxigenin antibody fragments coupled to horse-radish peroxidase (Boehringer-Mannheim). After pre-incubation in 2% non-immune horse serum (NHS) in PBST for 45 min at room temperature, the ovarioles were incubated overnight at 4°C in the presence of anti-digoxigenin antibody fragments (1/200 in PBST containing 1% NHS). Following extensive washing with PBST, hybridized RNA was detected by diaminobenzidine (DAB) staining as described (Robinow et al., 1993) . Follicles were dehydrated, mounted in Permount (Fisher) and examined under a Zeiss IM 35 inverted microscope equipped with Nomarski optics.
Gel retardation assays
A 1.2 kb NotI fragment, containing the coding region of BmHNF-4b, from its N-terminus to an internal NotI-site in its F domain, was cloned in pBS-SK + and used for expression in vitro. The plasmid was linearized with BamHI and transcribed in vitro using T3 RNA polymerase (Pharmacia). The transcribed RNA was translated in a rabbit reticulocyte lysate (Promega) using the manufacturer's protocols. The sequences used for in vitro transcription and translation yield a BmHNF-4b polypeptide extending from its N-terminus to the first 16 amino acids of the F domain plus an additional five amino acids encoded by sequences in the polylinker region of pBS-SK + . Gel mobility shift assays were carried out as described (Yao et al., 1993; Swevers et al., 1996) . Binding reactions contained 4 ml of a translation reaction or 2 mg of protein in nuclear extract. Nuclear extracts were prepared as previously described (Skeiky and Iatrou, 1991) . The binding probe was a 22 bp fragment containing an HNF-4 binding site derived from the promoter of the human apolipoprotein CIII gene (APF1) (Sladek et al., 1990 ; Fig. 6A ).
